Diagnostic Center | December 15, 2022
Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Subscribe To Our Newsletter & Stay Updated
